Format

Send to

Choose Destination
Genes Dev. 2015 Apr 15;29(8):817-31. doi: 10.1101/gad.255000.114. Epub 2015 Apr 6.

Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin.

Author information

1
Division of Cancer and Radiation Oncology, Department of Radiation Oncology, Stanford University, Stanford, California 94305, USA;
2
Division of Cancer and Radiation Oncology, Department of Radiation Oncology, Stanford University, Stanford, California 94305, USA; Department of Obstetrics and Gynecology, Stanford University, Stanford, California 94305, USA;
3
Department of Dermatology, Stanford University, Stanford, California 94305, USA;
4
Department of Anatomy and Cell Biology, Indiana School of Medicine, Indianapolis, Indiana 46202, USA; Department of Medicine, Indiana School of Medicine, Indianapolis, Indiana 46202, USA;
5
Division of Endocrinology, Department of Medicine, Indiana School of Medicine, Indianapolis, Indiana 46202, USA;
6
Department of Anatomy and Cell Biology, Indiana School of Medicine, Indianapolis, Indiana 46202, USA; Division of Endocrinology, Department of Medicine, Indiana School of Medicine, Indianapolis, Indiana 46202, USA;
7
Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University, Stanford, California 94305, USA.
8
Division of Cancer and Radiation Oncology, Department of Radiation Oncology, Stanford University, Stanford, California 94305, USA; giaccia@stanford.edu.

Abstract

The bone microenvironment is composed of niches that house cells across variable oxygen tensions. However, the contribution of oxygen gradients in regulating bone and blood homeostasis remains unknown. Here, we generated mice with either single or combined genetic inactivation of the critical oxygen-sensing prolyl hydroxylase (PHD) enzymes (PHD1-3) in osteoprogenitors. Hypoxia-inducible factor (HIF) activation associated with Phd2 and Phd3 inactivation drove bone accumulation by modulating osteoblastic/osteoclastic cross-talk through the direct regulation of osteoprotegerin (OPG). In contrast, combined inactivation of Phd1, Phd2, and Phd3 resulted in extreme HIF signaling, leading to polycythemia and excessive bone accumulation by overstimulating angiogenic-osteogenic coupling. We also demonstrate that genetic ablation of Phd2 and Phd3 was sufficient to protect ovariectomized mice against bone loss without disrupting hematopoietic homeostasis. Importantly, we identify OPG as a HIF target gene capable of directing osteoblast-mediated osteoclastogenesis to regulate bone homeostasis. Here, we show that coordinated activation of specific PHD isoforms fine-tunes the osteoblastic response to hypoxia, thereby directing two important aspects of bone physiology: cross-talk between osteoblasts and osteoclasts and angiogenic-osteogenic coupling.

KEYWORDS:

HIF signaling; bone homeostasis; hypoxia; osteoprotegerin; oxygen sensing; prolyl hydroxylase

PMID:
25846796
PMCID:
PMC4403258
DOI:
10.1101/gad.255000.114
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center